echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Beike Biotech IPO plans to publicly issue 41,284,070 shares, preliminary inquiry on June 9

    Beike Biotech IPO plans to publicly issue 41,284,070 shares, preliminary inquiry on June 9

    • Last Update: 2021-07-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Baike Biopharmaceuticals issued an announcement that it plans to IPO and list on the Science and Technology Innovation Board.
    The number of the company’s public offering of shares this time is 41,284,100 shares, accounting for approximately 10.
    00% of the post-issuance share capital; the original shareholders of this issuance will not conduct a public offering Shares
    .


    After the issuance, the total share capital will be 413 million shares


    The sponsor will arrange for the relevant subsidiary CITIC Securities Investment Co.


    It is reported that the net profit attributable to the owners of the parent company in 2018, 2019 and 2020 of Baike Bio will be 128 million yuan, 221 million yuan and 418 million yuan, respectively


    The funds raised by Baike Biology intend to invest in the following projects: 182 million yuan will be used in Changchun Baike Biotechnology Co.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.